1. Home
  2. IHRT vs DBVT Comparison

IHRT vs DBVT Comparison

Compare IHRT & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iHeartMedia Inc.

IHRT

iHeartMedia Inc.

HOLD

Current Price

$3.85

Market Cap

590.1M

ML Signal

HOLD

DBVT

DBV Technologies S.A.

HOLD

Current Price

$12.92

Market Cap

508.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IHRT
DBVT
Founded
1974
2002
Country
United States
France
Employees
10100
N/A
Industry
Broadcasting
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
590.1M
508.8M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
IHRT
DBVT
Price
$3.85
$12.92
Analyst Decision
Buy
Buy
Analyst Count
3
5
Target Price
$4.50
$15.85
AVG Volume (30 Days)
2.8M
142.0K
Earning Date
11-10-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,856,033,000.00
$5,502,000.00
Revenue This Year
$0.22
$1,743.46
Revenue Next Year
$6.06
$1,045.66
P/E Ratio
N/A
N/A
Revenue Growth
1.39
N/A
52 Week Low
$0.95
$2.74
52 Week High
$4.77
$18.00

Technical Indicators

Market Signals
Indicator
IHRT
DBVT
Relative Strength Index (RSI) 54.55 43.16
Support Level $3.65 $12.70
Resistance Level $3.97 $13.60
Average True Range (ATR) 0.26 0.93
MACD -0.07 -0.12
Stochastic Oscillator 26.84 22.09

Price Performance

Historical Comparison
IHRT
DBVT

About IHRT iHeartMedia Inc.

iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: